ReviewJournal of clinical medicine2022

Predictive Markers for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.

Ryota Ushio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.